Search results for "Cardiovascular events"
Evidence evolving on aspirin as prevention
Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
https://immattersacp.org/archives/2019/03/evidence-evolving-on-aspirin-as-prevention.htm
1 Mar 2019
Colonoscopy screening may be less beneficial for average-risk patients ages 75 and older
Screening colonoscopy may provide modest benefit in colorectal cancer prevention among patients ages 70 to 74 years of age but “a smaller (if any) benefit in those who are older,” a study found.
https://immattersacp.org/weekly/archives/2016/09/27/1.htm
27 Sep 2016
Adhering to hypertension guidelines could save lives, reduce costs
Fully implementing recent hypertension guidelines for adults ages 35 to 74 could potentially prevent about 56,000 cardiovascular events and 13,000 deaths annually, while saving money, a study found.
https://immattersacp.org/weekly/archives/2015/02/03/1.htm
3 Feb 2015
‘Nonfunctional’ adrenal tumors may be linked to incident diabetes
Risk for incident diabetes is significantly higher in patients with nonfunctional adrenal tumors than in those without, and the term “nonfunctional” may minimize the potential contribution of adrenal hormone secretion to cardiometabolic risk, researchers said.
https://immattersacp.org/weekly/archives/2016/08/02/1.htm
2 Aug 2016
Getting to know GLP-1 receptor agonists
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023
Subclinical eGFR associated with cardiovascular disease in younger patients
A retrospective cohort study in Canada found that the relative risk for major cardiovascular events with or without heart failure increased in adults ages 18 to 39 years with an eGFR below 80 mL/min/1.73 m2.
https://immattersacp.org/weekly/archives/2023/09/19/2.htm
19 Sep 2023
Aspirin for primary prevention should be better targeted, new study and FDA say
A recently published study and announcement from the FDA caution against wide use of aspirin for primary prevention of cardiovascular events.
https://immattersacp.org/weekly/archives/2014/05/13/2.htm
13 May 2014
Different patients, different doses
Some patients may metabolize certain drugs differently, requiring primary care physicians to know any safety or dosing issues for the most commonly used drugs.
https://immattersacp.org/archives/2019/05/different-patients-different-doses.htm
1 May 2019
Warning about contrast agents, reviews under way on Stalevo
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2010/11/fda.htm
1 Nov 2010
Screen for cardiovascular risk factors in Cushing's patients who use glucocorticoids
People who use glucocorticoids and exhibit iatrogenic Cushing's syndrome should be aggressively targeted for early screening and management of cardiovascular risk factors, a study found.
https://immattersacp.org/weekly/archives/2012/08/07/4.htm
7 Aug 2012